4//SEC Filing
GRANADILLO PEDRO P 4
Accession 0001140361-22-023147
CIK 0001281895other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 9:07 PM ET
Size
17.0 KB
Accession
0001140361-22-023147
Insider Transaction Report
Form 4
GRANADILLO PEDRO P
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-13+47,745→ 47,745 totalExercise: $10.77Exp: 2032-06-13→ Common Stock (47,745 underlying) - Award
Stock Option (Right to Buy)
2022-06-13$6.80/sh+10,283$69,924→ 10,283 totalExercise: $10.77Exp: 2032-06-13→ Common Stock (10,283 underlying)
Footnotes (2)
- [F1]This option represents a right to purchase a total of 47,745 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2023.
- [F2]This option represents a right to purchase a total of 10,283 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2023. This option was issued to the Reporting Person in lieu of director retainer fees of $70,000.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001217544
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 9:07 PM ET
- Size
- 17.0 KB